These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4073846

  • 1. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA, Emerson RG, Warner CL, Rowland LP, Salen G.
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [Abstract] [Full Text] [Related]

  • 2. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G, Berginer V, Shore V, Horak I, Horak E, Tint GS, Shefer S.
    N Engl J Med; 1987 May 14; 316(20):1233-8. PubMed ID: 3106810
    [Abstract] [Full Text] [Related]

  • 3. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
    Wolf LM, Houdent C, Laudat MH, Brasseur G, Balacheff O, Uzac L.
    Nouv Presse Med; 1982 Mar 06; 11(11):855-7. PubMed ID: 7070978
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug 06; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 6. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.
    Donaghy M, King RH, McKeran RO, Schwartz MS, Thomas PK.
    J Neurol; 1990 Jun 06; 237(3):216-9. PubMed ID: 2196342
    [Abstract] [Full Text] [Related]

  • 7. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH.
    Arch Neurol; 2002 Apr 06; 59(4):527-9. PubMed ID: 11939886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
    Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S.
    Metabolism; 1991 Jul 06; 40(7):741-6. PubMed ID: 1908036
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
    Tint GS, Ginsberg H, Salen G, Le NA, Shefer S.
    J Lipid Res; 1989 May 06; 30(5):633-40. PubMed ID: 2760539
    [Abstract] [Full Text] [Related]

  • 12. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.
    Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A.
    Arch Neurol; 1992 May 06; 49(5):469-75. PubMed ID: 1316120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cerebrotendinous xanthomatosis].
    Berginer VM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992 May 06; 92(4):13-22. PubMed ID: 1333699
    [Abstract] [Full Text] [Related]

  • 15. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
    Björkhem I, Skrede S, Buchmann MS, East C, Grundy S.
    Hepatology; 1987 May 06; 7(2):266-71. PubMed ID: 3557306
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM, Salen G, Shefer S.
    N Engl J Med; 1984 Dec 27; 311(26):1649-52. PubMed ID: 6504105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Two cases of familial cerebrotendinous xanthomatosis--intrahepatic enzyme assay and therapeutic trial with chenodeoxycholic acid].
    Orimo S, Kobayashi T, Furukawa T, Tsukagoshi H, Kano I.
    Rinsho Shinkeigaku; 1984 Jan 27; 24(1):38-44. PubMed ID: 6467736
    [No Abstract] [Full Text] [Related]

  • 19. [Cerebrotendinous xanthomatosis--a case of brain MRI abnormality and osteoporosis].
    Kubota R, Nakagawa M, Nakamura A, Kuriyama M, Osame M.
    Rinsho Shinkeigaku; 1992 May 27; 32(5):488-93. PubMed ID: 1333927
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.